Skip to main content

Asthma

Research Review
07/22/2026
Rebecca Mashaw
The findings of a recent study support further evaluation of targeted screening strategies to promote earlier diagnosis and improve care for children at increased risk of EoE, such as those with asthma.
The findings of a recent study support further evaluation of targeted screening strategies to promote earlier diagnosis and improve care for children at increased risk of EoE, such as those with asthma.
The findings of a recent study...
07/22/2026
Allergy & Immunology
Research Review
06/15/2026
Rebecca Mashaw
A recent systematic review suggests that uncontrolled asthma and exacerbations during pregnancy may elevate the risk of preeclampsia.
A recent systematic review suggests that uncontrolled asthma and exacerbations during pregnancy may elevate the risk of preeclampsia.
A recent systematic review...
06/15/2026
Allergy & Immunology
Michael Wechsler
Expert Insights
06/14/2026
Michael E. Wechsler, MD
Dr Wechsler reviews key updates to the Global Initiative for Asthma (GINA) 2026, including the addition of combination therapies and new biologics, new assessment methods, inhaler techniques, and more.
Dr Wechsler reviews key updates to the Global Initiative for Asthma (GINA) 2026, including the addition of combination therapies and new biologics, new assessment methods, inhaler techniques, and more.
Dr Wechsler reviews key updates...
06/14/2026
Allergy & Immunology
Research Highlights
05/06/2026
Jessica Garlewicz
Researchers found Bruton's tyrosine kinase inhibition was associated with a numerical decrease in loss of asthma control and may represent “a novel mechanism to treat uncontrolled symptomatic asthma.”
Researchers found Bruton's tyrosine kinase inhibition was associated with a numerical decrease in loss of asthma control and may represent “a novel mechanism to treat uncontrolled symptomatic asthma.”
Researchers found Bruton's...
05/06/2026
Allergy & Immunology
Research Highlights
04/01/2026
Riya Gandhi, MA
Sublingual immunotherapy achieved better asthma control and inflammatory biomarker reduction when compared to subcutaneous allergoid immunotherapy.
Sublingual immunotherapy achieved better asthma control and inflammatory biomarker reduction when compared to subcutaneous allergoid immunotherapy.
Sublingual immunotherapy...
04/01/2026
Allergy & Immunology
Research Review
03/18/2026
Rebecca Mashaw
Among the 150 children with asthma, those with higher Dietary Phytochemical Index intake had significantly better clinical scores and lower levels of inflammation than those in the lowest tertile.
Among the 150 children with asthma, those with higher Dietary Phytochemical Index intake had significantly better clinical scores and lower levels of inflammation than those in the lowest tertile.
Among the 150 children with...
03/18/2026
Allergy & Immunology
Research Highlights
03/02/2026
Jessica Garlewicz
A longitudinal analysis provides evidence that early-life feeding practices may influence immune and respiratory outcomes over decades.
A longitudinal analysis provides evidence that early-life feeding practices may influence immune and respiratory outcomes over decades.
A longitudinal analysis provides...
03/02/2026
Allergy & Immunology
Guidance
03/02/2026
Jessica Garlewicz
Although most recommendations mirror those for the general adult population, several key considerations are specific to asthma.
Although most recommendations mirror those for the general adult population, several key considerations are specific to asthma.
Although most recommendations...
03/02/2026
Allergy & Immunology
Research Summary
03/02/2026
Jessica Garlewicz
The findings underscore the importance of addressing quality-of-life domains that are not routinely assessed in asthma care.
The findings underscore the importance of addressing quality-of-life domains that are not routinely assessed in asthma care.
The findings underscore the...
03/02/2026
Allergy & Immunology
FDA Alert
02/18/2026
Jessica Garlewicz
Exdensur is the first ultra-long-acting biologic for this population, with a dosing schedule of just twice per year.
Exdensur is the first ultra-long-acting biologic for this population, with a dosing schedule of just twice per year.
Exdensur is the first...
02/18/2026
Allergy & Immunology
Research Highlights
02/17/2026
Jessica Garlewicz
The findings address a gap in OTC options for asthma management, where inhaled epinephrine remains the only nonprescription therapy in the United States.
The findings address a gap in OTC options for asthma management, where inhaled epinephrine remains the only nonprescription therapy in the United States.
The findings address a gap in...
02/17/2026
Allergy & Immunology